American Society of Hematology

ASH is the leader in representing the interests of scientists and clinicians working in the field of hematology on Capitol Hill and within federal agencies concerned with the study and treatment of blood-related diseases.


SCD Initiative 

Sickle Cell Disease Initiative

A multi-faceted initiative to identify the highest priority actions needed to improve the outcomes for individuals with SCD in the U.S. and globally.

Fight for Hematology 

Support Medical Research

Urge your members of Congress to support continued medial research funding.

Advocacy Leadership Institute

Provides opportunities to learn more about advocacy, health policy, and the legislative process, and to become engaged in the Society’s activities.

Congressional Fellowship

Provides education about the policy making process, including Congress’ relationship to the hematology community.

MACRA Resources

Get an overview of the Medicare Access and CHIP Reauthorization Act (MACRA) and its impact on hematology.

Drug Access Issues

Keep informed of newly approved therapies, safety and prescription matters, and shortages of critical hematologic drugs.

CAC Networking Meeting

Learn about the yearly ASH-ASCO Carrier Advisory Committee (CAC) Network Meeting.

  • Urge Your Senators and Representative to Support the Cancer Drug Coverage Parity Act

    Legislation has been reintroduced in the U.S. House of Representatives and U.S. Senate that would ensure that patients enrolled in certain federally regulated health plans have access and insurance coverage for all anti-cancer regimens. The Cancer Drug Coverage Parity Act (S.741 / H.R.1730) would require any health plan that provides coverage for cancer chemotherapy treatment to provide coverage for orally administered and self-injectable anticancer medications at a cost no less favorable than the cost of IV, port administered, or injected anticancer medications.

     

  • Join Your Hematology Colleagues to Take Action in Support of NIH and CDC Funding

    ASH members are urging lawmakers to reach a bipartisan agreement to raise the budget caps, which will allow Congress to support robust, sustained, and predictable funding increases for NIH in FY 2020 and beyond and to provide dedicated funding in FY 2020 for the SCD Data Collection program in the CDC’s Blood Disorders Division.  YOU can help spread this message by sending an email to your Senators and Representative in support of funding for NIH and CDC.

  • Introduce Yourself and Hematology to the New Congress

    Members of the 116th Congress, including 91 new Representatives and 9 new Senators, have been sworn into office and have already begun conducting legislative business.  These newly elected officials – along with returning Senators and Representatives – need to know what hematology is and how federal programs impact research and patients.

     

  • ASH Legislative Victory! Thank Congress for Passing Sickle Cell Disease Legislation

    Legislation with the goal of improving outcomes for patients with sickle cell disease (SCD) has successfully passed both chambers of Congress! For the past several years, ASH has met with congressional offices and called on members of the ASH Grassroots Network to take action in support of the Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act (S. 2465).  Because of your efforts and the work of ASH Grassroots Network advocates across the country, Congress is sending this important bill to the President to be signed into law.

View all action alerts
  • 2018 ASH Advocacy Activities

    ASH continues to increase its efforts to expand and enhance the Society’s reach. NIH funding, efforts to ensure patient access to drugs, and sickle cell disease were top priorities on ASH’s advocacy agenda in 2018.

  • 2018 ASH Advocacy Efforts Related to Sickle Cell Disease and Sickle Cell Trait

    ASH continues to invest in and explore the important actions needed to make a significant difference in sickle cell disease (SCD) access to care, research, and global issues. Learn about the major advocacy-related initiatives undertaken by ASH in 2018.

  • 2018 ASH Advocacy Efforts to Ensure Patient Access to Care

    In 2018, ASH worked to ensure patient access to care through a number of methods including ensuring drug access, pain management-related issues, and the Affordable Care Act.

  • 2018 Physician Payment Advocacy Highlights

    In 2018, ASH commented on numerous rules and regulations proposed by the Centers for Medicare and Medicaid Services (CMS), which impact physician payment. ASH is actively involved in various advisory committees and also continues to engage with lawmakers on Capitol Hill.

View all policy news
back to top